DK3648761T3 - Telmisartan til forebyggelsen eller behandlingen af hypertension i katte - Google Patents
Telmisartan til forebyggelsen eller behandlingen af hypertension i katte Download PDFInfo
- Publication number
- DK3648761T3 DK3648761T3 DK18740153.4T DK18740153T DK3648761T3 DK 3648761 T3 DK3648761 T3 DK 3648761T3 DK 18740153 T DK18740153 T DK 18740153T DK 3648761 T3 DK3648761 T3 DK 3648761T3
- Authority
- DK
- Denmark
- Prior art keywords
- telmisartan
- cats
- hypertension
- prevention
- treatment
- Prior art date
Links
- RMMXLENWKUUMAY-UHFFFAOYSA-N telmisartan Chemical compound CCCC1=NC2=C(C)C=C(C=3N(C4=CC=CC=C4N=3)C)C=C2N1CC(C=C1)=CC=C1C1=CC=CC=C1C(O)=O RMMXLENWKUUMAY-UHFFFAOYSA-N 0.000 title 2
- 239000005537 C09CA07 - Telmisartan Substances 0.000 title 1
- 206010020772 Hypertension Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 229960005187 telmisartan Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762529587P | 2017-07-07 | 2017-07-07 | |
| PCT/EP2018/068189 WO2019008077A1 (en) | 2017-07-07 | 2018-07-05 | ANTAGONIST OF THE ANGIOTENSIN II RECEPTOR FOR THE PREVENTION OR TREATMENT OF SYSTEMIC DISEASES IN CATS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3648761T3 true DK3648761T3 (da) | 2024-06-24 |
Family
ID=62904440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18740153.4T DK3648761T3 (da) | 2017-07-07 | 2018-07-05 | Telmisartan til forebyggelsen eller behandlingen af hypertension i katte |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US10905676B2 (da) |
| EP (2) | EP3648761B1 (da) |
| JP (2) | JP7050893B2 (da) |
| KR (3) | KR20230161541A (da) |
| CN (1) | CN110785168A (da) |
| AR (1) | AR112265A1 (da) |
| AU (1) | AU2018295387B2 (da) |
| BR (1) | BR112020000194A2 (da) |
| DK (1) | DK3648761T3 (da) |
| EA (1) | EA202090205A1 (da) |
| ES (1) | ES2979279T3 (da) |
| FI (1) | FI3648761T3 (da) |
| HR (1) | HRP20240703T1 (da) |
| HU (1) | HUE067255T2 (da) |
| LT (1) | LT3648761T (da) |
| NZ (1) | NZ759782A (da) |
| PL (1) | PL3648761T3 (da) |
| PT (1) | PT3648761T (da) |
| RS (1) | RS65570B1 (da) |
| SI (1) | SI3648761T1 (da) |
| TW (2) | TW202602498A (da) |
| WO (1) | WO2019008077A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220218671A1 (en) | 2019-07-09 | 2022-07-14 | Boehringer Ingelheim Vetmedica Gmbh | Telmisartan for the treatment of chronic kidney disease in dogs |
| MX2022000426A (es) | 2019-07-09 | 2022-04-25 | Boehringer Ingelheim Vetmedica Gmbh | Telmisartan para el tratamiento de la hipertension en perros. |
| TW202541793A (zh) | 2023-12-15 | 2025-11-01 | 德商百靈佳殷格翰維美迪加股份有限公司 | 用於預防貓之全身性疾病之血管緊張素ii受體拮抗劑 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5671074A (en) | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative |
| CA1334092C (en) | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
| US5015651A (en) | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
| CA1338238C (en) | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
| US4880804A (en) | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
| IE70593B1 (en) | 1989-09-29 | 1996-12-11 | Eisai Co Ltd | Biphenylmethane derivative the use of it and pharmacological compositions containing same |
| IL97219A (en) | 1990-02-19 | 1995-12-08 | Ciba Geigy Ag | Biphenyl substituted aliphatic amino compounds process for their preparation and pharmaceutical compositions containing them |
| TW201738B (da) | 1990-03-20 | 1993-03-11 | Sanofi Co | |
| US5196444A (en) | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
| IE912956A1 (en) | 1990-09-10 | 1992-03-11 | Abbott Lab | Angiotensin ii receptor antagonists |
| US6028091A (en) | 1990-12-14 | 2000-02-22 | Smithkline Beecham Plc | Medicament |
| GB9027210D0 (en) | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| SI9210098B (sl) | 1991-02-06 | 2000-06-30 | Dr. Karl Thomae | Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo |
| US5196537A (en) | 1991-03-21 | 1993-03-23 | G. D. Searle & Co. | 5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders |
| GB9110636D0 (en) | 1991-05-16 | 1991-07-03 | Glaxo Group Ltd | Chemical compounds |
| NZ251741A (en) | 1992-04-13 | 1997-06-24 | Zeneca Ltd | Use of angiotensin ii antagonists for treating disease conditions associated with impaired neuronal conduction velocity |
| CA2186606A1 (en) | 1994-03-29 | 1995-10-05 | Edward B. Nelson | Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles |
| DE19901921C2 (de) | 1999-01-19 | 2001-01-04 | Boehringer Ingelheim Pharma | Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels |
| US6358986B1 (en) | 1999-01-19 | 2002-03-19 | Boehringer Ingelheim Pharma Kg | Polymorphs of telmisartan |
| DE10018401A1 (de) | 2000-04-13 | 2001-10-25 | Boehringer Ingelheim Pharma | Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen |
| US20030073705A1 (en) | 2001-05-14 | 2003-04-17 | Shahnaz Shahinfar | Method of treatment |
| DE10153737A1 (de) | 2001-10-31 | 2003-05-28 | Boehringer Ingelheim Pharma | Kristallines Natriumsalz des Telmisartans, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels |
| US8980870B2 (en) | 2002-09-24 | 2015-03-17 | Boehringer Ingelheim International Gmbh | Solid telmisartan pharmaceutical formulations |
| EP1579862A1 (en) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
| US20070026026A1 (en) | 2005-08-01 | 2007-02-01 | David Delmarre | Oral liquid losartan compositions |
| EP1908469A1 (en) | 2006-10-06 | 2008-04-09 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin II receptor antagonist for the treatment of systemic diseases in cats |
| CA2653011A1 (en) * | 2008-12-03 | 2010-06-03 | Apotex Technologies Inc | Method and apparatus for packaging and dispensing pharmaceuticals |
| BRPI1013037A2 (pt) | 2009-05-20 | 2019-09-24 | Boehringer Ingelheim Ipharmaceuticals Inc | "solução farmacêutica oral de telmisartan" |
| HK1253373A1 (zh) * | 2015-06-10 | 2019-06-14 | Hackensack University Medical Center | 使用替米沙坦预防和治疗移植物抗宿主病及其他同种免疫性和自体免疫性疾病 |
| AU2017324406A1 (en) | 2016-09-07 | 2019-05-02 | Saniona A/S | Tesofensine compositions |
-
2018
- 2018-07-05 DK DK18740153.4T patent/DK3648761T3/da active
- 2018-07-05 TW TW114111277A patent/TW202602498A/zh unknown
- 2018-07-05 WO PCT/EP2018/068189 patent/WO2019008077A1/en not_active Ceased
- 2018-07-05 EP EP18740153.4A patent/EP3648761B1/en active Active
- 2018-07-05 CN CN201880033892.1A patent/CN110785168A/zh active Pending
- 2018-07-05 PL PL18740153.4T patent/PL3648761T3/pl unknown
- 2018-07-05 KR KR1020237039620A patent/KR20230161541A/ko not_active Ceased
- 2018-07-05 BR BR112020000194-5A patent/BR112020000194A2/pt not_active Application Discontinuation
- 2018-07-05 NZ NZ759782A patent/NZ759782A/en unknown
- 2018-07-05 KR KR1020247042412A patent/KR20250007040A/ko active Pending
- 2018-07-05 TW TW107123267A patent/TWI888340B/zh active
- 2018-07-05 EP EP23204038.6A patent/EP4299120A3/en active Pending
- 2018-07-05 EA EA202090205A patent/EA202090205A1/ru unknown
- 2018-07-05 JP JP2020500145A patent/JP7050893B2/ja active Active
- 2018-07-05 HR HRP20240703TT patent/HRP20240703T1/hr unknown
- 2018-07-05 SI SI201831100T patent/SI3648761T1/sl unknown
- 2018-07-05 KR KR1020207003639A patent/KR20200026975A/ko not_active Ceased
- 2018-07-05 PT PT187401534T patent/PT3648761T/pt unknown
- 2018-07-05 US US16/027,422 patent/US10905676B2/en active Active
- 2018-07-05 AR ARP180101883 patent/AR112265A1/es not_active Application Discontinuation
- 2018-07-05 LT LTEPPCT/EP2018/068189T patent/LT3648761T/lt unknown
- 2018-07-05 FI FIEP18740153.4T patent/FI3648761T3/fi active
- 2018-07-05 ES ES18740153T patent/ES2979279T3/es active Active
- 2018-07-05 RS RS20240617A patent/RS65570B1/sr unknown
- 2018-07-05 HU HUE18740153A patent/HUE067255T2/hu unknown
- 2018-07-05 AU AU2018295387A patent/AU2018295387B2/en active Active
-
2020
- 2020-12-22 US US17/131,312 patent/US20210106564A1/en active Pending
-
2022
- 2022-02-18 JP JP2022023799A patent/JP7402907B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3660004T3 (pl) | Związki i sposoby do ukierunkowanej degradacji receptora androgenowego | |
| IL282998A (en) | Pyridazinone compounds and uses thereof | |
| IL259441A (en) | Materials and methods for treatment of titin-based myopathies and other titinopaties | |
| EP3742602C0 (de) | Photovoltaik-anlage und zugehörige verwendung | |
| DK3562486T3 (da) | Anvendelse af sublingual dexmedetomidin til behandling af agitation | |
| IL278122B1 (en) | Pteridinone compounds and uses thereof | |
| IL255735A (en) | Anthelmintic depsipeptide compounds | |
| PL3257147T3 (pl) | Układ przetwornicy i sposób jego zabezpieczenia przeciwzwarciowego | |
| EP3686818C0 (en) | WATER TREATMENT SYSTEM | |
| DK3503890T3 (da) | Anvendelse af pridopidin til behandling af dystonier | |
| PL3672948T3 (pl) | Związki pirydynoamino-pirydonu i pirymidynoamino-pirydonu | |
| DK3164123T3 (da) | Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier | |
| DK3236960T3 (da) | Fluralaner til anvendelse i behandling af demodicose | |
| PL3573620T3 (pl) | Kompozycje do leczenia nadciśnienia | |
| DK3717011T5 (da) | Fremgangsmåde til behandling eller forebyggelse af iskæmi-reperfusionsskade | |
| DK3331610T3 (da) | Midler til anvendelse til behandling af gliom | |
| DK3709996T3 (da) | Coumarin-derivat til behandling eller forebyggelse af en celleproliferativ lidelse | |
| EP3606879A4 (en) | WATER TREATMENT SYSTEM | |
| DK3554501T3 (da) | Dexmedetomidin eller medetomidin til anvendelse i behandling af separationsangst hos kæledyr | |
| PL3373922T3 (pl) | Kompozycje i sposoby do stosowania do leczenia homocystynurii | |
| DK3648761T3 (da) | Telmisartan til forebyggelsen eller behandlingen af hypertension i katte | |
| DK3461967T3 (da) | Sternbåndsmonteret rækværkssystem | |
| DK3649043T3 (da) | Flugtsystem | |
| DK3621871T3 (da) | Flugtsystem | |
| EP3733160A4 (en) | EMULSIFIED COMPOSITION |